4

PRIMARY DOCUMENT

Company: AXIM BIOTECHNOLOGIES, INC.
Filed: March 3, 2015
Period of Report: February 23, 2015
Accession Number: 0001078782-15-000331

View Document ↗ View on SEC.gov ↗